|Year : 2017 | Volume
| Issue : 1 | Page : 16-20
A histopathologic review of cervical cancer in Kano, Nigeria
Alfa Alhaji Sule, Ochicha Ochicha
Department of Pathology, Bayero University, Aminu Kano Teaching Hospital, Kano, Nigeria
|Date of Web Publication||11-Apr-2017|
Alfa Alhaji Sule
Department of Pathology, Bayero University, Aminu Kano Teaching Hospital, Kano
Background: Although cervical cancer is the most common gynecological malignancy globally, with high incidence in developing countries, there has been no formal study in our locality. We, therefore, undertook this review to document and evaluate the pattern in Kano, Northern Nigeria. Materials and Methods: This is 10 years (2002–2011) retrospective study of all cervical cancers diagnosed at the Pathology Department of Aminu Kano Teaching Hospital, Kano. Results: Five hundred and forty-five cervical cancers were diagnosed during the 10 years study. Patients' ages ranged from 20 to 80 years (mean 48.30 ± standard deviation 12.61 years), with highest occurrence in the fifth to seventh decade age group. Squamous carcinoma was by far the most common histological type (82.2%), distantly followed by adenocarcinoma (12.8%) and mesenchymal/mixed Mullerian malignancies comprising 0.01% (5 cases). Conclusion: Our findings were consistent with most published reports in Nigeria and sub-Saharan Africa but somewhat at variance with the developed world where cervical cancer is much less common and afflicts a slightly older age group.
Keywords: Africa, cervical cancer, gynecological malignancies
|How to cite this article:|
Sule AA, Ochicha O. A histopathologic review of cervical cancer in Kano, Nigeria. Sahel Med J 2017;20:16-20
| Introduction|| |
Cancer of the cervix is the most common gynecological malignancy and the second most frequent cancer in women worldwide. The incidence is much higher in the developing world than it is in the developed world where widespread cervical smear screening has markedly lowered the incidence.
The introduction of human papillomavirus (HPV) vaccination programs among adolescent females in some developed countries is likely to widen the cervical cancer gap between developed and developing countries. Furthermore, the global HIV pandemic which has more severely impacted on sub-Saharan Africa and parts of the developing world also increases the burden of cervical cancer in the third world, as cervical cancer is an AIDS-defining malignancy.
Some studies also suggest a disparity in histological types between the first and third worlds., While squamous carcinoma remains overwhelmingly preponderant in the developing world, its frequency has slightly declined in the developed world, with relatively increased in the prevalence of adenocarcinoma.
In Nigeria, cervical cancer is the most frequent female genital malignancy, constituting 62.3–70.5% of gynecological cancers., There has, however, being no formal study of this common malignancy in Kano, the largest city in Northern Nigeria, hence this review. The aim of this study was to analyze the frequency and morphological patterns, as well as to compare our findings with other studies from different geographical locations of the world.
| Materials and Methods|| |
This is 10 years (2002–2011) retrospective review of all cervical malignancies diagnosed at the Pathology Department of Aminu Kano Teaching Hospital (AKTH). AKTH is the premier referral center in Kano state as well as some of the neighboring states.
Ethical clearance was obtained from hospital ethics committee and biodata derived from pathology laboratory records.
Histology slides on all cases were retrieved and reviewed by the authors. Fresh sections were cut from archival paraffin blocks when slides could not be retrieved.
All specimens had been fixed in 10% formal saline then routinely processed for paraffin embedding. Microtome sections were cut at 4 μ and stained with hematoxylin and eosin. Special stains such as mucicarmine for mucin were deployed where necessary. Biodata on all cases was retrieved from laboratory records. Collated results were presented in the form of tables and photomicrographs.
| Results|| |
A total of 545 histologically diagnosed cervical cancers were seen during the 10-year study. Patients' ages ranged from 20 to 80 years with mean of 48.3 years (±standard deviation 12.61). The overwhelming majority (80%) of patients were within the fifth to seventh decade age group, peaking in the 5th. Squamous carcinoma mostly occurred in a slightly older age group (fifth to seventh decades), than adenocarcinoma (fourth to sixth decades). Most 521 (95.6%) of the biopsies were incisional with only 24 (4.4%) being hysterectomies.
[Table 1] shows the relative frequency and age distribution of different histological types. Carcinomas were overwhelmingly preponderant comprising 99.1% (540 cases), distantly followed by 4 carcinosarcomas (0.7%) and one leiomyosarcoma (0.2%).
|Table 1: Histological types and age distribution of cervical cancers in Kano|
Click here to view
Squamous cell carcinoma was by far the most common histological type accounting for 82.2% (448 cases), followed by adenocarcinoma (12.8%), and other infrequent tumor subtypes.
Of the adenocarcinomas, nearly three-quarters were endometrioid (52 cases), with 12 clear cell and 6 mucinous subtypes.
[Table 2] and [Table 3] depict the age and frequency distribution of squamous versus nonsquamous cell malignancies of the cervix in Kano from 2002 to 2011. Comparing the two age groups [Table 2], the χ2 = 13.69 and P = 0.02.
|Table 2: Age distribution of squamous versus nonsquamous cell malignancies of the cervix in Kano from 2002 to 2011|
Click here to view
|Table 3: Frequency distribution of squamous versus nonsquamous cell malignancies of the cervix in Kano between 2002 and 2011|
Click here to view
[Figure 1] and [Figure 2] show the photo-micrograph of large cell nonkeratinizing squamous cell carcinoma and mucinous adenocarcinoma of the cervix respectively.
|Figure 1: Large cell nonkeratinizing squamous cell carcinoma (H and E ×20)|
Click here to view
| Discussion|| |
There were 545 cases of cervical cancers during the 10-year study which represents 46.6–58.5% of all gynecological cancers in Kano. This is consistent with most other sub-Saharan African studies but at variance with the developed world where cervical cancer is relatively less common and is exceeded by endometrial and ovarian cancers as the common gynecological malignancies.,
The overall age range of patients with invasive cervical cancer was 20–80 years, peaking in the fifth decade (131 cases). This was followed by patients in the sixth decade (127 cases). The mean age was 48.3 years, which is lower than most other parts of the world, the mean age was 47.9 years in Egypt, 52.1 years in Tunisia, 53 years in Brazil, 52.4 years in Italy, and 51.4 years in the USA.,,,, The mean age in this study corroborates other Nigerian studies – 44.5 years in Zaria, 42 years in Ibadan, and 48 years in Sokoto.,,
Thus, it appears the mean age in Nigeria is somewhat lower than most other middle and high-income countries. Racial differences, as well as environment factors like poor access to proper medical care with prompt treatment of synergistic sexually transmitted infections, are probably involved here in our environment.
In this series, 68% of squamous carcinomas occurred in the fifth to seventh decade. This is consistent with findings in other parts of the country where most patients fell within the 40–69 years age bracket.,,
Most 521 (95.6%) of the biopsies were incisional with only 24 (4.4%) being hysterectomies. Squamous cell carcinoma emerged the most frequent histological type, comprising about 82.2% of cases. This is quite similar to studies from other countries such as Tunisia (90.5%), India (90%), and the USA (85%).,, In other Nigerian studies, squamous cell carcinoma was also the most common with a prevalence of 95% in Zaria, 93% in Ibadan, 92% in Maiduguri, and 85.7% in Ilorin.,,, Nonkeratinizing type (46.2%) was the most common variant of squamous carcinoma in this study, followed by keratinizing variant (33%). This is similar to findings by Lowe et al. in Malawi and Mandong in Jos., It is at variance with studies in the USA, Ibadan, and Ilorin where nonkeratinizing squamous cell carcinomas comprised 61.2%, 63.2%, and 60.1%, respectively.,, Thus, there appears to be no consistent pattern within the country, or globally.
Adenocarcinoma was the second most common histological type in this study constituting 12.8% of cervical cancers in Kano. Although absolute number remains relatively small, increasing incidence of cervical adenocarcinoma has been reported in several developed nations.,
With just one leiomyosarcoma (0.2%) documented in this 10-year study, mesenchymal malignancies of the cervix were uncommon. This is comparable to 0.5% reported by Platz in the USA.
From result above, comparing the two periods with significant association (P = 0.02), it means that there may be an increase in squamous cell carcinomas over the nonsquamous cell malignancies in the study period. Furthermore, there was a gradual increase in frequencies of nonsquamous cell malignancies over the years during the study. This is mainly due to the effectiveness of cervical screening program, squamous cell carcinoma precursors are frequently detected in Pap smear More Detailss, and can generally be readily visualized by colposcopy and eradicated. On the other hand, adenocarcinoma precursors are often difficult to identify because it often arises deep in the endocervical canal, the area that is not easily sampled during a routine screening and hence invasive adenocarcinoma is often present by the time the tumor is detected.
| Conclusion|| |
Cervical cancer is quite common in our setting which necessitates data for health planning and policy decisions. Recommendations include health education and awareness on the need for all women to have Pap smear screening from puberty, cervical smear screening (training of cytoscreeners, funding for free screening, etc.), HPV vaccination, colposcopy training for Gynecologists, provision of radiotherapy facilities for cancer treatment, facilities and training in cytogenetic techniques for HPV typing in pathology laboratories.
We are grateful to Mr. Sani for laboratory work.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Denny L. The prevention of cervical cancer in developing countries. BJOG 2005;112:1204-12.
Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al.
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9.
Moodley M, Moodley J, Kleinschmidt I. Invasive cervical cancer and human immunodeficiency virus (HIV) infection: A South African perspective. Int J Gynecol Cancer 2001;11:194-7.
Odida M, Schmauz R, Lwanga SK. Grade of malignancy of cervical cancer in regions of Uganda with varying malarial endemicity. Int J Cancer 2002;99:737-41.
Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
Hemminki K, Li X, Vaittinen P. Time trends in the incidence of cervical and other genital squamous cell carcinomas and adenocarcinomas in Sweden, 1958-1996. Eur J Obstet Gynecol Reprod Biol 2002;101:64-9.
Uzoigwe SA, Seleye-Fubara D. Cancers of the uterine cervix in Port Harcourt, Rivers State – A 13-year clinico-pathological review. Niger J Med 2004;13:110-3.
Oguntayo O, Zayyan M, Kolawole A, Adewuyi S, Ismail H, Koledade K. Cancer of the cervix in Zaria, Northern Nigeria. Ecancermedicalscience 2011;5:219.
Elorbany SM, Helwa R, El-Shalakany AH, Eldin ZA, Tharwat AA, Koleib MH. Prevalence and genotype distribution of HPV types in Egyptian women with cervical carcinoma and pre-invasive lesions. Br J Obstet Gynecol 2013;86:5.
Missaoui N, Trabelsi A, Landolsi H, Jaidaine L, Mokni M, Korbi S, et al.
Cervical adenocarcinoma and squamous cell carcinoma incidence trends among Tunisian women. Asian Pac J Cancer Prev 2010;11:777-80.
Brenna SM, Zeferino LC, Pinto GA, Souza RA, Andrade LA, Vassalo J, et al.
C-Myc protein expression is not an independent prognostic predictor in cervical squamous cell carcinoma. Braz J Med Biol Res 2002;35:425-30.
Giorgi Rossi P, Sideri M, Carozzi FM, Vocaturo A, Buonaguro FM, Tornesello ML, et al
.HPV type distribution in invasive cervical cancers in Italy: Pooled analysis of three large studies. Infect Agent Cancer 2012;7:26.
Chan PG, Sung HY, Sawaya GF. Changes in cervical cancer incidence after three decades of screening US women less than 30 years old. Obstet Gynecol 2003;102:765-73.
Mohammed A, Ahmed SA, Oluwole OP, Avidime S. Malignant tumours of the female genital tract in Zaria, Nigeria. Ann Afr Med 2006;5:93-6.
Babarinsa A, Akang EE, Adewole IF. Pattern of gynecological malignancies at the Ibadan cancer registry (1976-1995). Nig Q J Hosp Med 1998;8:103-6.
Airede LR, Malami SA. A five year review of female genital tract malignancies in Sokoto, Northwestern Nigeria. Mary Slessor J Med 2005;5:51-6.
Kyari O, Nggada H, Mairiga A. Malignant tumours of female genital tract in North Eastern Nigeria. East Afr Med J 2004;81:142-5.
Terris M, Wilson F, Nelson JH Jr. Comparative epidemiology of invasive carcinoma of the cervix, carcinoma in situ
, and cervical dysplasia. Am J Epidemiol 1980;112:253-7.
Ijaiya MA, Aboyeji PA, Buhari MO. Cancer of the cervix in Ilorin, Nigeria. West Afr J Med 2004;23:319-22.
Lowe D, Jorrizzo J, Chipang WD. Cervical cancer in Malawi. A histopathological study of 460 cases. Cancer 1981;47:2493-8.
Mandong BM, Ujah IA, Uguru VE. Clinico-pathological study of carcinoma of the cervix in Jos, Nigeria. Nig Med Pract 1997;34:76-9.
Berrington de González A, Sweetland S, Green J. Comparison of risk factors for squamous cell and adenocarcinomas of the cervix: A meta-analysis. Br J Cancer 2004;90:1787-91.
Smith HO, Tiffany MF, Qualls CR, Key CR. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States – a 24-year population-based study. Gynecol Oncol 2000;78:97-105.
Platz CE, Benda JA. Female genital tract cancer. Cancer 1995;75 1 Suppl: 270-94.
Gien LT, Beauchemin MC, Thomas G. Adenocarcinoma: A unique cervical cancer. Gynecol Oncol 2010;116:140-6.
[Figure 1], [Figure 2]
[Table 1], [Table 2], [Table 3]